EAM
Eventide Asset Management Portfolio holdings
AUM
$5.71B
This Quarter Return
+2.92%
1 Year Return
+51.18%
3 Year Return
+209.28%
5 Year Return
+283.63%
10 Year Return
+1,480.39%
AUM
$7.56B
AUM Growth
+$7.56B
(+1.6%)
Cap. Flow
+$133M
Cap. Flow
% of AUM
1.75%
Top 10 Holdings %
Top 10 Hldgs %
25.56%
Holding
165
New
13
Increased
52
Reduced
26
Closed
13
Top Buys
| 1 |
DICE
DICE Therapeutics, Inc. Common Stock
DICE
|
$59.2M |
| 2 |
FIVE9
FIVN
|
$46.1M |
| 3 |
Xometry
XMTR
|
$42M |
| 4 |
Global E Online
GLBE
|
$34.3M |
| 5 |
Fiverr
FVRR
|
$28.7M |
Top Sells
| 1 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$92.5M |
| 2 |
TRIL
Trillium Therapeutics Inc.
TRIL
|
$75.2M |
| 3 |
Celldex Therapeutics
CLDX
|
$53M |
| 4 |
BridgeBio Pharma
BBIO
|
$43.4M |
| 5 |
RingCentral
RNG
|
$33.8M |
Sector Composition
| 1 | Healthcare | 34.45% |
| 2 | Technology | 30.19% |
| 3 | Industrials | 13.01% |
| 4 | Consumer Discretionary | 7.21% |
| 5 | Communication Services | 4.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BCYC
51
Bicycle Therapeutics
BCYC
$492M
| $48.4M | 0.64% |
1,163,471
| – | – |
|
52
Annexon
ANNX
$225M
| $47.1M | 0.62% |
2,531,628
+122,462
| +5% | +$2.28M |
|
53
nCino
NCNO
$3.55B
| $47.1M | 0.62% |
662,500
| – | – |
|
|
SMAR
54
DELISTED
Smartsheet Inc.
SMAR
| $45.7M | 0.6% |
664,131
-32,000
| -5% | -$2.2M |
|
55
Brookfield Renewable
BEP
$7B
| $45.6M | 0.6% |
1,236,000
| – | – |
|
56
Sutro Biopharma
STRO
$85.6M
| $44.8M | 0.59% |
2,370,975
| – | – |
|
57
Novanta
NOVT
$4.05B
| $43.3M | 0.57% |
280,000
| – | – |
|
58
Immunovant
IMVT
$2.91B
| $43M | 0.57% |
4,950,000
+1,579,006
| +47% | +$13.7M |
|
|
59
Xometry
XMTR
$2.37B
| $42.8M | 0.56% |
742,802
+727,802
| +4,852% | +$42M |
|
60
Verisk Analytics
VRSK
$37.5B
| $42.7M | 0.56% |
213,000
| – | – |
|
61
Clearway Energy Class C
CWEN
$3.38B
| $42.5M | 0.56% |
1,402,600
+99,200
| +8% | +$3M |
|
62
MongoDB
MDB
$25.5B
| $42.1M | 0.56% |
89,355
| – | – |
|
63
Compass
COMP
$4.76B
| $40.6M | 0.54% |
3,065,563
+1,043,532
| +52% | +$13.8M |
|
|
TPTX
64
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $38.4M | 0.51% |
578,000
| – | – |
|
65
Monolithic Power Systems
MPWR
$39.6B
| $37.5M | 0.5% |
77,459
| – | – |
|
66
Pliant Therapeutics
PLRX
$105M
| $36.9M | 0.49% |
2,183,238
-288,654
| -12% | -$4.87M |
|
|
BPMC
67
DELISTED
Blueprint Medicines
BPMC
| $36.6M | 0.48% |
356,000
-105,712
| -23% | -$10.9M |
|
68
Nurix Therapeutics
NRIX
$723M
| $36M | 0.47% |
1,200,000
| – | – |
|
69
ADC Therapeutics
ADCT
$370M
| $35.6M | 0.47% |
1,311,990
| – | – |
|
70
Brookfield Renewable
BEPC
$5.92B
| $35.6M | 0.47% |
916,319
+7,400
| +0.8% | +$287K |
|
71
Zentalis Pharmaceuticals
ZNTL
$123M
| $35.3M | 0.46% |
529,000
+108,600
| +26% | +$7.24M |
|
72
Repligen
RGEN
$6.54B
| $34.4M | 0.45% |
119,000
| – | – |
|
|
73
Global E Online
GLBE
$5.69B
| $34.3M | 0.45% |
+478,198
| New | +$34.3M |
|
|
74
RingCentral
RNG
$2.74B
| $32M | 0.42% |
147,308
-155,300
| -51% | -$33.8M |
|
75
Cullinan Oncology
CGEM
$456M
| $31.7M | 0.42% |
1,440,145
| – | – |
|